Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04837196
Title Study of ASP7517 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors Expressing WT1 Antigen
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Astellas Pharma Global Development, Inc.
Indications

melanoma

Advanced Solid Tumor

ovarian cancer

colorectal cancer

Therapies

ASP7517 + Pembrolizumab

ASP7517

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Emory University Recruiting Atlanta Georgia 30322 United States Details
University of Chicago Recruiting Chicago Illinois 60603 United States Details
University of Iowa Hospitals Recruiting Iowa City Iowa 52242 United States Details
UPCI Hillman Cancer Center Recruiting Pittsburgh Pennsylvania 15232 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field